Safety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial Hypercholesterolemia
Clinical trial NCT03403374 · COMPLETED
Trial details
- NCT number
- NCT03403374
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-04
- Primary completion
- 2019-11-27
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.